Literature DB >> 11180223

FMR1 gene and fragile X syndrome.

B Bardoni1, J L Mandel, G S Fisch.   

Abstract

Taxonomic features of fragile X syndrome (FXS) associated with the fragile X mutation have evolved over several decades. Males are more severely impacted cognitively than females, but both show declines in IQ scores as they age. Although many males with FXS exhibit autistic-like features, autism does not occur more frequently in males with FXS than among males with mental retardation (MR). FXS is caused by inactivation of the FMR1 gene located on Xq27.3. FMRP, the protein produced by FMR1, has been detected in most organs and in brain. In cells, it is located primarily in cytoplasm and contains motifs found in RNA-binding proteins. The FMRP N-terminal contains a functional nuclear localization signal which permits the protein to shuttle between cytoplasm and nucleus. FMR1 knockout mice show subtle behavioral and visual-spatial difficulties. Analysis of their brain tissue suggests absence of FMRP impairs synaptic maturation. Individuals with the fragile premutation produce FMRP, and the phenotype associated with the premutation has been controversial. However, there seems to be a higher incidence of premature ovarian failure in women with the premutation than is found in the general female population. This may be related to unusual increases in mRNA levels in premutation carriers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11180223     DOI: 10.1002/1096-8628(200022)97:2<153::aid-ajmg7>3.0.co;2-m

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  15 in total

Review 1.  Genetic effects on human cognition: lessons from the study of mental retardation syndromes.

Authors:  P Nokelainen; J Flint
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

Review 2.  Insights into brain development from neurogenetic syndromes: evidence from fragile X syndrome, Williams syndrome, Turner syndrome and velocardiofacial syndrome.

Authors:  E Walter; P K Mazaika; A L Reiss
Journal:  Neuroscience       Date:  2009-04-17       Impact factor: 3.590

3.  Dendritic spine instability and insensitivity to modulation by sensory experience in a mouse model of fragile X syndrome.

Authors:  Feng Pan; Georgina M Aldridge; William T Greenough; Wen-Biao Gan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-22       Impact factor: 11.205

4.  Phenotypes of Drosophila brain neurons in primary culture reveal a role for fascin in neurite shape and trajectory.

Authors:  Robert Kraft; Mindy M Escobar; Martha L Narro; Jackie L Kurtis; Alon Efrat; Kobus Barnard; Linda L Restifo
Journal:  J Neurosci       Date:  2006-08-23       Impact factor: 6.167

5.  Fronto-striatal dysfunction and potential compensatory mechanisms in male adolescents with fragile X syndrome.

Authors:  Fumiko Hoeft; Arvel Hernandez; Sudharshan Parthasarathy; Christa L Watson; Scott S Hall; Allan L Reiss
Journal:  Hum Brain Mapp       Date:  2007-06       Impact factor: 5.038

6.  Modeling Fragile X syndrome in neurogenesis: An unexpected phenotype and a novel tool for future therapies.

Authors:  Barbara Bardoni; Maria Capovilla; Enzo Lalli
Journal:  Neurogenesis (Austin)       Date:  2017-01-31

7.  Animal models of autism spectrum disorders: information for neurotoxicologists.

Authors:  Alycia K Halladay; David Amaral; Michael Aschner; Valerie J Bolivar; Aaron Bowman; Emanuel DiCicco-Bloom; Susan L Hyman; Flavio Keller; Pamela Lein; Isaac Pessah; Linda Restifo; David W Threadgill
Journal:  Neurotoxicology       Date:  2009-07-09       Impact factor: 4.294

Review 8.  Serotonin dysregulation in Fragile X Syndrome: implications for treatment.

Authors:  Alicia C Hanson; Randi J Hagerman
Journal:  Intractable Rare Dis Res       Date:  2014-11

9.  The expanding genomic landscape of autism: discovering the 'forest' beyond the 'trees'

Authors:  Valerie W Hu
Journal:  Future Neurol       Date:  2013-01-01

10.  Glycogen synthase kinase-3: a promising therapeutic target for fragile x syndrome.

Authors:  Marjelo A Mines; Richard S Jope
Journal:  Front Mol Neurosci       Date:  2011-11-01       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.